Ascentage Pharma Group International (AAPG) Ownership
AAPG ownership summary
as of October 18, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 0.00% of shares outstanding
- Shares outstanding
- 93.4M
- Float
- 71.5M shares available to trade
- Short interest
- 0.01% 9,250 shares short
- Days to cover
- 1.45 short interest down 53.4% vs prior month
- Institutions 0.04%
- Other investors 99.96%
AAPG top institutional holders
15 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management, L.P. | 0.01% | 14K | $212,736 | −2,215 (−13.8%) | June 30, 2026 |
| 2 | Morgan Stanley - Brokerage Accounts | <0.01% | 919 | $14,125 | +421 (+84.5%) | June 30, 2026 |
| 3 | Wells Fargo & Co | <0.01% | 200 | $3,074 | +200 (0.0%) | June 30, 2026 |
| 4 | EverSource Wealth Advisors, LLC | 0.00% | 24 | $369 | — | June 30, 2026 |
| 5 | UBS Group AG | 0.00% | 15 | $231 | −109 (−87.9%) | June 30, 2026 |
| 6 | BlackRock Inc | 0.00% | 6 | $92 | +6 (0.0%) | June 30, 2026 |
| 7 | Royal Bank of Canada | 0.00% | 6 | $92 | — | June 30, 2026 |
| 8 | Caitong International Asset Management Co., Limited. | 0.00% | 1 | $15 | +1 (0.0%) | June 30, 2026 |
| 9 | Bell Investment Advisors, Inc | 0.00% | — | — | −67 (−100.0%) | March 31, 2026 |
| 10 | Tower Research Capital LLC | 0.00% | — | — | −518 (−100.0%) | June 30, 2026 |
| 11 | Citadel Advisors Llc | 0.00% | — | — | −9,737 (−100.0%) | March 31, 2026 |
| 12 | XY Capital Ltd | 0.00% | — | — | −13,014 (−100.0%) | June 30, 2026 |
| 13 | Advisor Group Holdings, Inc. | 0.00% | — | — | −220 (−100.0%) | March 31, 2026 |
| 14 | Mirae Asset Global Investments (Korea) Co Ltd | 0.00% | — | — | −2,546 (−100.0%) | March 31, 2026 |
| 15 | Bank of America Corp | 0.00% | — | — | −201 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 15, 4 holders added 628 shares and 9 cut 29K.
AAPG top mutual fund and ETF holders
1 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Fidelity Nasdaq Composite Index | <0.01% | 1,558 | $23,946 | — | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
AAPG shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns AAPG
Institutional investors own 0.0% of Ascentage Pharma Group International's shares and insiders 0.00%. The largest holder is Point72 Asset Management, L.P. with 0.01% of the shares (14K), as of June 30, 2026. Among the top 15 institutions, 4 added shares and 9 reduced their stake in the latest filings. Short interest is 0.01% of the float, or 1.45 days of average trading volume. The share count rose 615.5% since 2016.
Related: AAPG analyst forecast, AAPG key metrics. See the AAPG stock overview for the latest quote and news.
AAPG ownership FAQ
Who owns the most Ascentage Pharma Group International stock?
The largest shareholders of Ascentage Pharma Group International are Point72 Asset Management, L.P. (0.01%), Morgan Stanley - Brokerage Accounts (<0.01%), Wells Fargo & Co (<0.01%), EverSource Wealth Advisors, LLC (0.00%), UBS Group AG (0.00%).
What percentage of Ascentage Pharma Group International is owned by institutions?
Institutions hold 0.0% of Ascentage Pharma Group International's shares outstanding; insiders hold 0.00%.
Which funds own Ascentage Pharma Group International?
The largest fund holders of Ascentage Pharma Group International are Fidelity Nasdaq Composite Index (<0.01%).
What is Ascentage Pharma Group International's short interest?
9,250 shares of Ascentage Pharma Group International were sold short, 0.01% of the float; at the average daily volume it would take 1.45 days to cover.
How many shares of Ascentage Pharma Group International are outstanding?
Ascentage Pharma Group International has 93.4M shares outstanding, of which 71.5M are in the public float.